Acute community-acquired meningitis and encephalitis

Deborah C Saltman, Miles H Beaman and Steven L Wesselingh
Med J Aust 2002; 177 (5): . || doi: 10.5694/j.1326-5377.2002.tb04771.x
Published online: 2 September 2002

In reply: We thank Saltman for up-to-date information on Wyeth vaccines. Readers will appreciate that our article1 was commissioned in January 2001, and the manuscript delivered in August that year, before the licensing of Meningitec. As the article discussed, group C meningococcus is a minority strain in most regions of Australia. Hence, the vaccine will not prevent most cases of what is already an uncommon disease. Conjugate pneumococcal vaccines should have much wider application in the future, but currently are subsidised for use in only a minority of the at-risk population.

  • Deborah C Saltman
  • Miles H Beaman
  • Steven L Wesselingh

  • 1 Wyeth Australia, Baulkham Hills, NSW.
  • 2 Department of Infectious Diseases, Fremantle Hospital, Fremantle, WA.
  • 3 Infectious Diseases Unit, Alfred Hospital, Melbourne, VIC.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.